| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |